Viewpoint: How European GMO restrictions are hurting development of genetically-based therapeutics

Viewpoint: How European GMO restrictions are hurting development of genetically-based therapeutics

Lexology |
There aren’t enough viruses. At least, there are not enough engineered ones, the viral vectors used in gene therapies such ...